Sick relies on industrial AI and innovative strength
The company achieved solid results despite a difficult financial year 2024
Turnover fell by 8.9% to 2,103 million euros, influenced by negative currency effects. EBIT fell by 51.4% to 91.9 million euros. The decline in sales was stronger in Germany and Asia-Pacific, while regions such as EMEA and the Americas remained more stable. Sick invested heavily in research and development, particularly in Industrial AI, in order to strengthen its market position.
The focus is on the further development of sensor solutions and the integration of AI in order to increase productivity and efficiency. The strategic partnership with Endress+Hauser led to a restructuring of the workforce. Sick expects economic challenges to continue in 2025, but is relying on automation and AI to remain profitable. Automation remains a growth market, driven by technological advances, according to a Sick spokesperson.
